Atlanpole Biotherapies
Atlanpole Biotherapies is a French non-profit biocluster based in Nantes that connects 200-plus biotech, pharma, MedTech, digital health, and disease-prevention members across Pays de la Loire, Bretagne, and Centre-Val de Loire, delivering networking, innovation-project support, international expansion, and visibility services funded by regional councils and EU programs.
- Company typePrivate
- Founded2005
- HeadquartersSaint-germain-de-la-grange, France
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Atlanpole Biotherapies does
Atlanpole Biotherapies is a French non-profit cluster organization (association loi 1901) governed under the umbrella of GIP ATLANPOLE (Syndicat Mixte Atlanpole), a public interest group. Founded in 2005 and headquartered at Château de la Chantrerie in Nantes, the cluster coordinates health-innovation activity across three French regions — Pays de la Loire, Bretagne, and Centre-Val de Loire — serving a network of more than 200 members that includes roughly 150 companies, 30 research organizations, and 25 economic development structures. Its members span biotech and bioproduction, pharma, MedTech, Digital Health (e.g., Isidoctor, Orikio), and Disease Prevention, with member logos ranging from early-stage startups (Biodyssey, CXS Therapeutics, SPyDiag, Perha Pharmaceuticals, Xenothera, Procope Medicals) to commercial-stage enterprises (Valneva, Laboratoires Brothier) and large public institutions (CHU Nantes).
The cluster delivers four core services rather than technology products: Diversify Your Network (workshops, themed day meetings, conferences, partner introductions), Broaden Your Horizons (international congress access, EU-network inter-clustering, funding pathways), Develop Your Innovation Projects (feasibility studies, partner identification, project filing, cluster labeling), and Enhance Your Public Profile (monthly French newsletter, website, press releases, LinkedIn). Its distribution model relies on direct engagement with members, the Atlanpole partner-club referral channel, and participation in European inter-cluster projects including CE4BIG (with BioM, BioWin, Life Science Krakow), CEBR, Boost4Health, Atlantic Ket Med, and the upcoming MEDI4Future Interreg project scheduled for April 2026.
The revenue and funding model is non-commercial: Atlanpole Biotherapies is financed through public sources including Région Bretagne, Région Pays de la Loire, Région Centre-Val de Loire, French national government, and EU program grants (e.g., a €3M European grant within the €5M Boost4Health consortium). Pricing for cluster membership and services is not publicly disclosed. The organization operates with a small team of 11-50 employees led by Director Florence Hallouin, with Elodie Girardet managing European projects and Simon Boisserpe serving as Data Protection Officer. No venture capital, private equity, or external investment ownership is indicated, consistent with its status as a publicly funded competitiveness cluster ("pôle de compétitivité").
Atlanpole Biotherapies firmographics
Firmographics- Name
- Atlanpole Biotherapies
- Legal name
- Atlanpole Biotherapies
- Website
- https://atlanpolebiotherapies.eu
- Company type
- Private
- Founded year
- 2005
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Atlanpole Biotherapies is a French non-profit biocluster based in Nantes that connects 200-plus biotech, pharma, MedTech, digital health, and disease-prevention members across Pays de la Loire, Bretagne, and Centre-Val de Loire, delivering networking, innovation-project support, international expansion, and visibility services funded by regional councils and EU programs.
- Ownership category
- akta.pro rank
Atlanpole Biotherapies industry classification
Industry- Product category
- Biotechnology Cluster Services
- SIC
- Services-Membership Organizations (8600)
- akta.pro primary industry
- Global Health Research, Evidence & Technical Assistance Organizations (HLAJAKAN)
- akta.pro secondary industry
- Circularity Consulting & Program Management (EPR, Design-for-Circularity, LCA) (EUAIANAH)
Keywords
Where Atlanpole Biotherapies is headquartered
LocationHeadquarters
- HQ city
- Saint-germain-de-la-grange
- HQ country
- France
- HQ region
- Europe
Offices1 record
Markets served
Atlanpole Biotherapies business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales
Revenue model
- Cluster membership services: Atlanpole Biotherapies operates as a non-profit organization providing cluster services to members including networking, innovation project support, international expansion, and visibility enhancement. The organization is funded through public sources including regional councils (Région Bretagne, Région Pays de la Loire, Région Centre-Val de Loire) and European programs.
Go-to-market motion1 record
Distribution channels3 records
Marketing channels7 records
Atlanpole Biotherapies product offering
Product offeringCore offering
Atlanpole Biotherapies is a French non-profit biocluster that delivers four core cluster services to biotech, pharma, MedTech, and digital health organizations across the Pays de la Loire, Bretagne, and Centre-Val de Loire regions: network diversification through cluster events and meetings, international expansion support via congresses and European networks, innovation project development assistance including feasibility studies and partner matching, and public profile enhancement through newsletters, press releases, and digital channels. The organization operates as an association governed by the French Act of 1901 under the umbrella of GIP ATLANPOLE.
Product overview
Atlanpole Biotherapies operates as a multi-service cluster platform rather than a traditional product company. It provides four interconnected core services: (1) Diversify your network, enabling members to boost business and develop collaborations through cluster events; (2) Broaden your horizons, offering international access to congresses, forums, and funding; (3) Develop your innovation projects, providing personalized support for biotech/health tech projects from feasibility to labeling; and (4) Enhance your public profile, promoting members through newsletters, website, press releases, and social media. The organization also maintains a network of over 200 members including companies, research organizations, and economic development structures across biotherapies, MedTech, Digital Health, and Disease Prevention sectors.
Differentiator
Problem solved
Functional benefit
Products and services
- Diversify your network A cluster service enabling members to boost their business and develop new collaborations by joining the network, participating in workshops, themed day meetings, conferences, and pharmaceutical industry meetings. Targeted at biotech, pharma, MedTech, and digital health member organizations.
- Broaden your horizons International expansion support service providing members access to international congresses and forums, the cluster's international network, and specific funding opportunities for internationalization.
- Develop your innovation projects Personalized support for innovation projects in biotechnology or health technology sectors, including feasibility studies, partner identification, project filing, and cluster labeling. Targeted at entrepreneurs, researchers, clinicians, and pharmaceutical industry professionals.
- Enhance your public profile Visibility and promotion service that relays member news through a monthly French newsletter, dedicated website, press releases, and social networks including LinkedIn to enhance the public profile of cluster members.
Companies that use Atlanpole Biotherapies
Customer profileNamed customers12 records
Segments6 records
Ideal customer profiles4 records
Atlanpole Biotherapies technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Atlanpole Biotherapies partnerships and signals
Strategic signalPartnerships
14 partnerships are on record, tiered minor and core.
- MEDI4FutureminorInterreg North-West Europe project (2026-04 launch) focused on reducing waste in MedTech sector and promoting circular solutions. 11 partners from 6 European countries targeting 2.5 million tonnes annual healthcare waste reduction.
- CEBR (Council of European Bioregions)coreMembership-driven network of lifescience clusters across Europe with approximately 40 subscription members. CEBR objectives include improving cluster support, reducing fragmentation, and transforming competitiveness into cooperation between regions.
- CE4BIG Consortium (Cluster Excellence for Business Innovation and Growth)coreEU COSME funded project with four European healthcare clusters: Atlanpole Biotherapies (France), BioM (Germany), BioWin (Belgium), Life Science Krakow (Poland). Focuses on personalized medicine and SME support through ClusterXchange scheme.
- Boost4HealthcoreEuropean INTERREG project for SMEs providing access to services, expert networks, and partners in Germany, Denmark, Netherlands, UK, Belgium, and Spain. €5M total budget with €3M European grant. Distributed €53,000 to cluster SMEs, coached 8 companies to pitch in English.
- AtlanpolecoreParent organization (Syndicat Mixte Atlanpole) providing umbrella structure for Atlanpole Biotherapies and Atlanpole Entreprises entities. Located at Château de la Chantrerie, 95 route de Gachet, BP 90702, 44300 Nantes.
- Biotech Santé BretagnecoreRegional biotechnology and healthcare sector structuring organization supporting innovative project leaders through consulting, partner matchmaking, project engineering, and access to funding.
- Région BretagnecoreRegional council providing public funding and support for the cluster's activities in Brittany region.
- Région Pays de la LoirecoreRegional council providing public funding and support for the cluster's activities in Pays de la Loire region where the cluster is primarily based.
- Région Centre-Val de LoireminorRegional council providing public funding and support for the cluster's activities in Centre-Val de Loire region.
- BioM (Germany)minorGerman health cluster partner in CE4BIG consortium, focused on advanced therapies for personalized medicine.
- BioWin (Belgium)minorBelgian health cluster partner in CE4BIG consortium, focused on advanced therapies for personalized medicine.
- Life Science Krakow (Poland)minorPolish health cluster partner in CE4BIG consortium, focused on advanced therapies for personalized medicine.
- Atlantic Ket MedminorEuropean project run by Galway University (Ireland), financed by Northern-West Europe Interreg. Brings new high-tech pilot production capacity for KETs-based medical devices to EU Atlantic Area.
- Les pôles de compétitivitécoreFrench competitiveness clusters organization providing label and framework for the cluster network.
Scale indicators3 records
Recent moves6 records
Expansion highlights4 records
Atlanpole Biotherapies competitors and assessment
Company assessmentOthers
- Council of European Bioregions (CEBR): Network of ~40 European life science clusters of which Atlanpole is a member; comparable organizational form (cluster association) operating one level up as a meta-network rather than as a regional cluster.
- Atlanpole Entreprises: Sister association under the same GIP ATLANPOLE umbrella providing broader technology/SME cluster services; an enabling peer sharing the same parent entity and overlapping member base in the Pays de la Loire ecosystem.
Direct peers
- BioWin: Belgian health and biotech competitiveness cluster (Wallonia) and CE4BIG partner, focused on advanced therapies and personalized medicine; near-identical cluster mandate serving SMEs, research institutes, and academic hospitals.
- Eurobiomed: French competitiveness cluster covering PACA, Occitanie, and Corsica focused on diagnostics, therapeutics, and MedTech — directly overlaps with Atlanpole's biotech/pharma/MedTech focus within the same national ecosystem.
- Lyonbiopôle: French Auvergne-Rhône-Alpes competitiveness cluster for health technologies (biotech, MedTech, digital health); comparable service pillars in networking, innovation funding, and internationalization for health SMEs.
- BioM: German biotech cluster (Munich/Bavaria) and CE4BIG partner, offering network, funding access, and internationalization services to biotech SMEs — directly comparable mandate and member base to Atlanpole Biotherapies.
- Life Science Krakow Cluster: Polish life sciences cluster and CE4BIG partner with ESCA Silver Label; comparable services in networking, innovation project support, and internationalization for life science SMEs.
- Biotech Santé Bretagne: Regional biotech/health sector structuring organization in Brittany, providing consulting, partner matchmaking, and funding access — a regional French peer with overlapping service model.
Emerging players
- Inserm Transfert: French technology transfer office of Inserm (public biomedical research), providing partnership, licensing, and SME creation services — overlapping with Atlanpole's biotech innovation support mandate at the academic/research interface.
Broad incumbents
- Medicen Paris Region: Larger French competitiveness cluster covering Île-de-France health innovation ecosystem; broader geographic scope and deeper pharma industry access make it a broader incumbent in the same national cluster landscape.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Atlanpole Biotherapies social profiles
Digital presenceAtlanpole Biotherapies financial estimates
Financial estimateRevenue estimate
Valuation estimate
Atlanpole Biotherapies leadership team
Management profileNumber of profiles
Profiles3 records
Atlanpole Biotherapies funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Atlanpole Biotherapies M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Atlanpole Biotherapies
What does Atlanpole Biotherapies do?
Atlanpole Biotherapies is a French non-profit biocluster that delivers four core cluster services to biotech, pharma, MedTech, and digital health organizations across the Pays de la Loire, Bretagne, and Centre-Val de Loire regions: network diversification through cluster events and meetings, international expansion support via congresses and European networks, innovation project development assistance including feasibility studies and partner matching, and public profile enhancement through newsletters, press releases, and digital channels. The organization operates as an association governed by the French Act of 1901 under the umbrella of GIP ATLANPOLE.
Is Atlanpole Biotherapies a public or private company?
Atlanpole Biotherapies is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was Atlanpole Biotherapies founded?
Atlanpole Biotherapies was founded in 2005. It employs 11 to 50 people.
Where is Atlanpole Biotherapies based?
Atlanpole Biotherapies is headquartered in Saint-germain-de-la-grange, France, in the Europe region.
How does Atlanpole Biotherapies make money?
One revenue line is on record: cluster membership services.
Who are Atlanpole Biotherapies's main competitors?
Others on record are Council of European Bioregions (CEBR) and Atlanpole Entreprises. Direct peers are BioWin, Eurobiomed, Lyonbiopôle, BioM, Life Science Krakow Cluster and Biotech Santé Bretagne. Inserm Transfert is listed as an emerging player. Medicen Paris Region is listed as a broad incumbent.
Does Atlanpole Biotherapies have an API?
No public API is recorded for Atlanpole Biotherapies.
What industry is Atlanpole Biotherapies in?
Atlanpole Biotherapies's product category is Biotechnology Cluster Services. Its primary akta.pro industry code is HLAJAKAN, Global Health Research, Evidence & Technical Assistance Organizations, with a secondary code of EUAIANAH, Circularity Consulting & Program Management (EPR, Design-for-Circularity, LCA). Its SIC code is 8600.